Epidemiology of venous thromboembolism in neonates and children

Elizabeth A Chalmers1

  • 1Department of Haematology, Royal Hospital for Sick Children, Glasgow G3 8SJ, Scotland, UK. elizabeth.chalmers@yorkhill.scot.nhs.uk

Thrombosis Research
|May 20, 2006
PubMed

Insights

Pediatric venous thromboembolism is a growing concern, especially in specialized care. Studies reveal distinct risk factors and incidence across age groups, necessitating tailored guidelines for children and neonates.

Area of Science:

  • Pediatric Hematology
  • Vascular Medicine
  • Clinical Epidemiology

Background:

  • Venous thromboembolism (VTE) is a significant and increasing issue in pediatric healthcare.
  • Tertiary care settings, particularly those serving neonates and children, report a higher prevalence.
  • Existing research highlights the need for age-specific understanding and management strategies.

Purpose of the Study:

  • To define the epidemiology of VTE in neonates and children.
  • To identify incidence and risk factors associated with VTE in different pediatric age groups.
  • To underscore the necessity for evidence-based guidelines tailored to pediatric VTE.

Main Methods:

  • Analysis of national and international VTE registries.
  • Epidemiological studies focusing on neonates and children.
  • Comparative analysis of pediatric versus adult VTE data.

Main Results:

  • Registries have provided crucial data on VTE incidence in pediatric populations.
  • Key risk factors for VTE in neonates and children have been identified.
  • Significant differences exist between pediatric and adult VTE patterns.

Conclusions:

  • Pediatric VTE requires specific attention due to its increasing recognition.
  • Data underscore the unique aspects of VTE in children compared to adults.
  • Development of evidence-based guidelines for pediatric VTE prevention and management is essential.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...